Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply.
作者信息
Hurwitz Shelley, Maurer Rie, Solomon Joshua J, Rosas Ivan O
机构信息
Brigham and Women's Hospital, Boston, MA, USA.
National Jewish Health, Denver, CO, USA.
出版信息
Lancet Respir Med. 2023 Jun;11(6):e52. doi: 10.1016/S2213-2600(23)00131-5. Epub 2023 Mar 29.
Abstract
摘要
相似文献
1
Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply.吡非尼酮治疗类风湿关节炎相关间质性肺疾病——作者回复
Lancet Respir Med. 2023 Jun;11(6):e52. doi: 10.1016/S2213-2600(23)00131-5. Epub 2023 Mar 29.
2
Pirfenidone in rheumatoid arthritis-associated interstitial lung disease.吡非尼酮治疗类风湿关节炎相关间质性肺疾病
Lancet Respir Med. 2023 Jun;11(6):e51. doi: 10.1016/S2213-2600(23)00130-3. Epub 2023 Mar 29.
3
The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.Trail1 试验的设计与原理：吡非尼酮治疗类风湿关节炎相关间质性肺病的随机、双盲、2 期临床试验。
Adv Ther. 2019 Nov;36(11):3279-3287. doi: 10.1007/s12325-019-01086-2. Epub 2019 Sep 12.
4
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.吡非尼酮治疗类风湿关节炎相关间质性肺疾病患者的安全性、耐受性和疗效：一项随机、双盲、安慰剂对照、2 期研究。
Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5.
5
Methotrexate in interstitial lung disease associated with rheumatoid arthritis.甲氨蝶呤用于治疗类风湿关节炎相关间质性肺疾病。
Reumatol Clin (Engl Ed). 2022 Aug-Sep;18(7):441-442. doi: 10.1016/j.reumae.2020.10.009. Epub 2022 Jul 18.
6
Rheumatoid arthritis associated interstitial lung disease: a review.类风湿关节炎相关间质性肺疾病：综述
Medicina (B Aires). 2014;74(2):158-65.
7
Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3).吡非尼酮通过下调激活转录因子 3（ATF3）抑制类风湿关节炎相关间质性肺病成纤维细胞向肌成纤维细胞转化。
Int Immunopharmacol. 2019 Sep;74:105700. doi: 10.1016/j.intimp.2019.105700. Epub 2019 Jun 19.
8
A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.一例类风湿关节炎患者在接受托珠单抗治疗期间发生间质性肺病急性加重导致的致命病例。
Rheumatol Int. 2012 Dec;32(12):4023-6. doi: 10.1007/s00296-010-1525-z. Epub 2010 May 18.
9
Comment on: Impact of interstitial lung disease on clinical remission of rheumatoid arthritis: results from the IORRA cohort: Reply.关于《间质性肺疾病对类风湿关节炎临床缓解的影响：来自IORRA队列的结果》的评论：回复
Rheumatology (Oxford). 2024 Apr 2;63(4):e134-e135. doi: 10.1093/rheumatology/kead511.
10
[Interstitial lung disease in rheumatoid arthritis].[类风湿关节炎中的间质性肺疾病]
Rev Med Suisse. 2011 Nov 23;7(318):2272-7.
Zotero 插件